New Biomarkers Evaluating Ovarian Cancer

Completed

Conditions studied: Adnexal Mass

In brief

The purpose of this study is to evaluate new biomarkers for patients presenting to a physician for surgery to remove a mass in their pelvis and to continue to evaluate these types of patients using the ROMA algorithm for post-market benefits.

Key facts

Study ID

NCT01466049

Run by

Fujirebio Diagnostics, Inc.

People needed

280

Starts

2011-12-01

Expected to finish

2014-03-01

Last updated by the study team

2014-08-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female, age 18 years or older
• Adnexal mass present documented by imaging
• Scheduled to undergo surgery based on a finding of adnexal mass
• Able and willing to provide Informed Consent

You may not qualify if…

• Previous history of ovarian cancer
• Previous history of bilateral oophorectomy
• Currently known to be pregnant
• Unable to provide informed consent

Where it is running

• New Hanover Regional Medical Center — Wilmington, North Carolina, United States
• University of Oklahoma — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.